Protagenic Therapeutics, Inc.\new Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Protagenic Therapeutics, Inc.\new Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$641K, a 54.1% increase year-over-year.
  • Protagenic Therapeutics, Inc.\new Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$5.65M, a 43.9% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Net Income (Loss) Attributable to Parent for 2023 was -$5M, a 40.6% decline from 2022.
  • Protagenic Therapeutics, Inc.\new annual Net Income (Loss) Attributable to Parent for 2022 was -$3.56M, a 21.4% increase from 2021.
  • Protagenic Therapeutics, Inc.\new annual Net Income (Loss) Attributable to Parent for 2021 was -$4.52M, a 77.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$5.65M -$641K +$756K +54.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$6.4M -$1.61M -$397K -32.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$6.01M -$1.72M -$1.01M -140% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$5M -$1.68M -$1.07M -179% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
Q3 2023 -$3.93M -$1.4M -$471K -50.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$3.45M -$1.21M -$543K -81.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$2.91M -$718K +$644K +47.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$3.56M -$601K +$289K +32.5% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 -$3.84M -$925K -$47K -5.35% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$3.8M -$667K +$881K +56.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$4.68M -$1.36M -$156K -12.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$4.52M -$890K -$367K -70% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$4.16M -$878K +$168K +16% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$4.32M -$1.55M -$1.07M -222% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$3.26M -$1.21M -$708K -142% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$2.55M -$524K +$226K +30.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-07
Q3 2020 -$2.77M -$1.05M -$923K -748% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.85M -$480K -$202K -72.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$1.65M -$499K +$101K +16.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$1.75M -$750K +$39.8K +5.04% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$1.79M -$123K +$374K +75.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$2.16M -$279K +$394K +58.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-16
Q1 2019 -$2.56M -$599K -$1.07K -0.18% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-16
Q4 2018 -$2.56M -$790K -$93.5K -13.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-29
Q3 2018 -$2.46M -$498K -$42.9K -9.45% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$2.42M -$672K -$221K -49% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$2.2M -$598K +$59.7K +9.07% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$2.26M -$696K -$140K -25.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$2.12M -$455K +$909 +0.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$2.12M -$451K +$73.4K +14% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$2.19M -$658K +$81.9K +11.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$2.28M -$556K -$398K -252% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$1.88M -$455K -$16K -3.64% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$1.86M -$524K -$415K -381% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$1.45M -$740K -$702K -1858% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$744K -$158K -$25K -18.8% Oct 1, 2015 Dec 31, 2015 10-Q 2016-03-11
Q3 2015 -$719K -$439K -$327K -292% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-17
Q2 2015 -$392K -$109K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$37.8K +$332K +89.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-07-25
Q4 2014 -$133K +$87K +39.5% Oct 1, 2014 Dec 31, 2014 10-Q 2016-03-11
Q3 2014 -$112K +$282K +71.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q1 2014 -$370K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$220K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 -$394K Jul 12, 2013 Sep 30, 2013 10-Q 2014-11-13
Q3 2011 -$4.52M -$886K -24.4% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 -$6.15M -$1.66M -37% Apr 1, 2011 Jun 30, 2011 10-Q/A 2011-09-07
Q3 2010 -$3.64M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.49M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.